Drug · DIN 02406233
UVADEX
TO BE ADMINSTERED VIA THE UVAR XTS OR THERAKOS CELLEX PHOTOPHERESIS SYSTEMS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 9, 2013; first marketed December 9, 2013.
- Drug Identification Number (DIN)
- 02406233
- Company (DIN owner)
- Therakos IncBridgewater, New Jersey, United States
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Extracorporeal
- Therapeutic class (ATC)
- Methoxalen, systemic D05BA02
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHOXSALEN | 20 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 9, 2013: NOC 14356New Drug Submission (NDS)